Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958615 · ClinicalTrials.gov registry record · NA
Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners
A NA study of Obesity, Morbid, sponsored by Larissa McGarrity, Ph.D..
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05958615: Active NA study of Obesity, Morbid, sponsored by Larissa McGarrity, Ph.D..
NCT05958615 is a NA study of Obesity, Morbid that is active but no longer recruiting, run by Larissa McGarrity, Ph.D.. The registered enrollment target is 80 participants, below the 99-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05958615, a NA study of Obesity, Morbid, is active but no longer recruiting, sponsored by Larissa McGarrity, Ph.D..
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this waitlist-control design, pilot randomized controlled trial is to test feasibility, acceptability, and preliminary efficacy of a remotely-delivered dyadic positive psychology intervention for patients 2 years after bariatric surgery and their romantic partners (called ReConnect). The main question it aims to answer is whether the intervention results in improvements in depressive symptoms for patients and partners. The additional questions it aims to answer are whether the intervention results in improvements in resilience, relationship satisfaction, eating and physical activity behaviors, and weight maintenance for those in the intervention versus waitlist control condition. Participant couples randomly assigned to the intervention condition will engage in ReConnect for 8 weekly modules and associated positive psychology activities, some individually and some as a couple. Participant couples randomly assigned to the waitlist control condition will wait for 8 weeks to begin the 8 week intervention. All participants will fill out assessment measures at baseline, 8 weeks, and 16 weeks.
Primary Outcome
Patient Health Questionnaire-9 (PHQ-9) Measured Scale 0 - 27 (0 = minimum - 27 = maximum), the higher the score the worse depressive symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Reimagining Us in the Context of Bariatric Surgery (ReConnect)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT05958615 still lists
NCT05958615 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 99-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (19% lower).
The record links to 1 condition, with Obesity, Morbid appearing as the primary indexed condition, and to 1 intervention - of which Reimagining Us in the Context of Bariatric Surgery (ReConnect) is the first listed.
NCT05958615 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05958615 about?
NCT05958615 is a clinical study titled "Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners". The goal of this waitlist-control design, pilot randomized controlled trial is to test feasibility, acceptability, and preliminary efficacy of a remotely-delivered dyadic positive psychology intervention for patients 2 years after bariatric surgery and their romantic partners (called ReConnect). Th...
What is the current status of trial NCT05958615?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-02-12. Estimated completion is 2026-11-30.
What conditions does trial NCT05958615 study?
This clinical trial studies the following conditions: Obesity, Morbid.
What interventions are being tested in trial NCT05958615?
The interventions under investigation include: Reimagining Us in the Context of Bariatric Surgery (ReConnect) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05958615?
This trial is sponsored by Larissa McGarrity, Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05958615 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Morbid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05958615's enrollment target sits among peer trials
80 5th of 19 higher than 15 of 19 other Obesity, Morbid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Morbid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Time-restricted Eating Among Pregnant Females With Severe Obesity
RECRUITING · NA
-
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis
RECRUITING · NA
-
Brown Adipose Tissue Activation by Spinal Cord Stimulation
RECRUITING · NA
-
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
RECRUITING · NA
-
Responsive Neurostimulation For Loss Of Control Eating
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI